Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2018-03-08 (8 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CHELLES (77500), Seine-et-Marne
PHARMACIE CHEAK : revenue, balance sheet and financial ratios
PHARMACIE CHEAK is a French company
founded 8 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CHELLES (77500),
this company of category PME
shows in 2023 a revenue of 3.6 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE CHEAK (SIREN 838013126)
Indicator
2025
2024
2023
2022
2021
2020
2019
Revenue
N/C
N/C
3 619 553 €
3 699 553 €
N/C
N/C
N/C
Net income
259 323 €
239 363 €
216 038 €
351 927 €
220 082 €
220 062 €
87 167 €
EBITDA
N/C
N/C
369 937 €
513 264 €
N/C
N/C
N/C
Net margin
N/C
N/C
6.0%
9.5%
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE CHEAK generates positive net income of 259 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2025: 87 k€ -> 259 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
259 323 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 79%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 49%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
78.838%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
48.558%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
2024
2025
Debt ratio
2929.341
769.588
411.363
227.509
148.862
107.621
78.838
Financial autonomy
2.88
10.008
17.089
26.416
34.119
41.317
48.558
Repayment capacity
None
None
None
5.317
5.704
None
None
Cash flow / Revenue
None%
None%
None%
10.189%
7.902%
None%
None%
Sector positioning
Debt ratio
78.842025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average-11 pts over 3 years
In 2025, the debt ratio of PHARMACIE CHEAK (78.84) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
48.56%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average+12 pts over 3 years
In 2025, the financial autonomy of PHARMACIE CHEAK (48.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
5.7 years2023
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Average
In 2023, the repayment capacity of PHARMACIE CHEAK (5.70) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 213.29. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
213.294
Liquidity indicators evolution PHARMACIE CHEAK
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
0.0
148.969
131.003
163.468
146.53
135.16
213.294
Interest coverage
None
None
None
4.058
4.645
None
None
Sector positioning
Liquidity ratio
213.292025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Good+30 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE CHEAK (213.29) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
4.64x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Good
In 2023, the interest coverage of PHARMACIE CHEAK (4.6x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 155 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 1046 days. Excellent situation: suppliers finance 891 days of the operating cycle (retail model).
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
155 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
1046 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE CHEAK
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
0 €
0 €
281 573 €
385 844 €
0 €
0 €
Inventory turnover (days)
0
0
0
33
39
0
0
Customer payment term (days)
0
0
0
8
4
145
155
Supplier payment term (days)
0
0
0
37
46
746
1046
Positioning of PHARMACIE CHEAK in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE CHEAK is estimated at
4 119 376 €
(range 2 795 428€ - 6 463 869€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
2795k€4119k€6463k€
4 119 376 €Range: 2 795 428€ - 6 463 869€
NAF 5 année 2025
Valuation method used
Net Income Multiple
259 323 €
×
15.9x
=4 119 377 €
Range: 2 795 428€ - 6 463 869€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE CHEAK with other companies in the same sector:
Yes, PHARMACIE CHEAK generated a net profit of 259 k€ in 2025.
Where is the headquarters of PHARMACIE CHEAK ?
The headquarters of PHARMACIE CHEAK is located in CHELLES (77500), in the department Seine-et-Marne.
Where to find the tax return of PHARMACIE CHEAK ?
The tax return of PHARMACIE CHEAK is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE CHEAK operate?
PHARMACIE CHEAK operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart